Drug manufacturers Moderna and Merck say a personalized mRNA cancer vaccine plus a drug called Keytruda reduced the return and spread of melanoma in high-risk patients. Dr. Jon LaPook and trial researcher Dr.
Source: [CBS News](https://www.cbsnews.com/video/this-mrna-vaccine-could-potentially-prevent-the-deadliest-form-of-skin-cancer/)